90 related articles for article (PubMed ID: 16219132)
1. [Enhancive effect of histone deacetylase inhibitor trichostatin a on transfection efficiency of adenovirus in ovarian carcinoma cell line A2780].
Chen G; Wang BB; Li FJ; Liu DY; Zhou JF; Lu YP; Ma D
Ai Zheng; 2005 Oct; 24(10):1196-200. PubMed ID: 16219132
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of coxsackie adenovirus receptor on invasive and metastatic phenotype of ovarian cancer cell line SKOV3].
Wang BB; Chen G; Li FJ; Zhou JF; Lu YP; Ma D
Ai Zheng; 2005 Sep; 24(9):1054-8. PubMed ID: 16159424
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application.
Pong RC; Roark R; Ou JY; Fan J; Stanfield J; Frenkel E; Sagalowsky A; Hsieh JT
Cancer Res; 2006 Sep; 66(17):8822-8. PubMed ID: 16951199
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the adenoviral sensitivity of human ovarian cancer cells by transient expression of coxsackievirus and adenovirus receptor (CAR).
Kim JS; Lee SH; Cho YS; Choi JJ; Kim YH; Lee JH
Gynecol Oncol; 2002 May; 85(2):260-5. PubMed ID: 11972385
[TBL] [Abstract][Full Text] [Related]
5. Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228.
Kitazono M; Goldsmith ME; Aikou T; Bates S; Fojo T
Cancer Res; 2001 Sep; 61(17):6328-30. PubMed ID: 11522619
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of conditionally replicating adenovirus and histone deacetylase inhibitors.
Kim DR; Park MY; Lim HJ; Park JS; Cho YJ; Lee SW; Yoon HI; Lee JH; Kim YS; Lee CT
Int J Mol Med; 2012 Feb; 29(2):218-24. PubMed ID: 22075951
[TBL] [Abstract][Full Text] [Related]
7. A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells.
Okegawa T; Sayne JR; Nutahara K; Pong RC; Saboorian H; Kabbani W; Higashihara E; Hsieh JT
J Urol; 2007 Mar; 177(3):1148-56. PubMed ID: 17296436
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL.
El-Zawahry A; Lu P; White SJ; Voelkel-Johnson C
Cancer Gene Ther; 2006 Mar; 13(3):281-9. PubMed ID: 16167063
[TBL] [Abstract][Full Text] [Related]
10. Deletion of the intracellular domain of coxsackie and adenovirus receptor (CAR) enhances the expression of itself and boosts the efficiency of current adenovirus-mediated gene therapy in ovarian cancer cell lines in vitro.
Wang B; Chen G; Zhou J; Wu P; Luo D; Huang X; Zhu T; Han Z; Xu G; Wang S; Lu Y; Ma D
Cancer Lett; 2007 Apr; 248(2):299-307. PubMed ID: 17166654
[TBL] [Abstract][Full Text] [Related]
11. The improvement of adenovirus vector production by increased expression of coxsackie adenovirus receptor.
Liu X; Wang Y; Niu H; Zhang X; Tan WS
Biotechnol Lett; 2009 Jul; 31(7):939-44. PubMed ID: 19330491
[TBL] [Abstract][Full Text] [Related]
12. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N
Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259
[TBL] [Abstract][Full Text] [Related]
13. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells.
Sachs MD; Ramamurthy M; Poel Hv; Wickham TJ; Lamfers M; Gerritsen W; Chowdhury W; Li Y; Schoenberg MP; Rodriguez R
Cancer Gene Ther; 2004 Jul; 11(7):477-86. PubMed ID: 15118762
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated thymidine kinase gene therapy and coxsackie adenovirus receptor expression in ovarian cancer cells.
Kieback DG
Cancer Genomics Proteomics; 2008; 5(6):311-8. PubMed ID: 19287072
[TBL] [Abstract][Full Text] [Related]
16. Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer.
Auer D; Reimer D; Porto V; Fleischer M; Roessler J; Wiedemair A; Marth C; Müller-Holzner E; Daxenbichler G; Zeimet AG
Breast Cancer Res Treat; 2009 Jul; 116(1):103-11. PubMed ID: 18618240
[TBL] [Abstract][Full Text] [Related]
17. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
Dressel U; Renkawitz R; Baniahmad A
Anticancer Res; 2000; 20(2A):1017-22. PubMed ID: 10810390
[TBL] [Abstract][Full Text] [Related]
18. Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression.
You Z; Fischer DC; Tong X; Hasenburg A; Aguilar-Cordova E; Kieback DG
Cancer Gene Ther; 2001 Mar; 8(3):168-75. PubMed ID: 11332987
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure.
Okegawa T; Pong RC; Li Y; Bergelson JM; Sagalowsky AI; Hsieh JT
Cancer Res; 2001 Sep; 61(17):6592-600. PubMed ID: 11522659
[TBL] [Abstract][Full Text] [Related]
20. Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression.
Hemminki A; Kanerva A; Liu B; Wang M; Alvarez RD; Siegal GP; Curiel DT
Cancer Res; 2003 Feb; 63(4):847-53. PubMed ID: 12591736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
